DRKS00011790
Recruiting
未知
Identification of individual cancer mutations and analysis of their immunogenicity - RB_T002
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- cancer
- Sponsor
- BioNTech SE
- Enrollment
- 1000
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •signed informed consent; Health condition, that allows planned interventions (according clinical standards);
- •Hemoglobin value \= 10,0 g / dl;
- •Patient with suspected/confirmed malign tumor with either already excised/planned excision of tumor material and/or possibility of tumor biopsies exclusively taken for the research project
Exclusion Criteria
- •Known pregnancy or breastfeeding;
- •Known acute or chronically active hepatitis infection, known HIV infection;
- •Patients who are incapable to give consent or are not able to understand the nature of the project;
- •serious concomitant disease or other circumstances (e.g. psychological, familial, sociological or geographical circumstances), which do not allow an adequate participation
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Identification of mutated and non-mutated tumor-associated antigens in glioblastomaglioblastomaglioblastoma multiforme10029211NL-OMON38803Academisch Medisch Centrum5
Not yet recruiting
Not Applicable
Identification of Genetic Changes in Indian Lung Cancer PatientsHealth Condition 1: C34- Malignant neoplasm of bronchus andlungCTRI/2019/12/022284DST INSPIRE Fellowship
Not yet recruiting
Not Applicable
Brain tumor biomarker studyHealth Condition 1: C719- Malignant neoplasm of brain, unspecifiedCTRI/2021/01/030566Johns Hopkins University School of Medicine
Recruiting
Not Applicable
Elucidation of treatment-specific gene mutation by liquid biopsy in patients with soft tissue sarcomasadvanced soft tissue sarcomasJPRN-UMIN000038273Orthopaedic surgery, Nagoya University Hospital15
Completed
Not Applicable
Cancer related gene alteration analysis study in patients with endometrial cancerendometrial cancerJPRN-UMIN000027294SRL Medisearch Inc.200